MarketWatch Automation
Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -0.90% advanced 9.99% to $91.79 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +1.37% rising 2.08% to 14,490.37 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.17% rising 0.86% to 35,768.06. Novavax Inc. closed $231.76 below its 52-week high ($323.55), which the company achieved on February 10th.
The stock outperformed some of its competitors Wednesday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL +3.26% rose 1.89% to $18.83, VBI Vaccines Inc. /zigman2/quotes/201705917/lastsale VBIV +2.18% rose 3.13% to $1.65, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +2.24% rose 3.85% to $32.35. Trading volume (5.3 M) remained 1.5 million below its 50-day average volume of 6.8 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.











